Company profile
Alnylam Pharmaceuticals
Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep pipeline and global reach.
- Industry
- Biotechnology Research
- Employees
- 2,916
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2002
- LinkedIn followers
- 291,409
- Office locations
- 9
Alnylam Pharmaceuticals company summary
Alnylam Pharmaceuticals is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2002. On LinkedIn the company has around 2,916 employees and 291,409 followers. Warmrank detected 36 technologies across 21 categories on alnylam.com, including Amazon SES, Amazon Web Services, Apple iCloud Mail. The company lists 9 office locations. Its listed specialties include Biotech, Pharmaceuticals, Biopharma, Drug Development, Rare Diseases.
What technology does Alnylam Pharmaceuticals use?
Warmrank detected 36 technologies on alnylam.com, last checked July 2026. Click any tool to see other companies that use it.
Miscellaneous
DocuSign
Open Graph
WebpackJavaScript libraries
OWL Carousel
Slick
Underscore.js
jQuery
Google Analytics
Hotjar
Linkedin Insight Tag
Fastly
Google Hosted Libraries
jsDelivr
Amazon SES
Mailgun
Amazon Web Services
Pantheon
Apple iCloud Mail
Microsoft 365Caching
VarnishShow 12 more technologiesShow fewer technologies
CMS
DrupalCookie compliance
OneTrustCRM
SalesforceDatabases
MariaDBFont scripts
Font AwesomeMaps
Google MapsProgramming languages
PHPSSL/TLS certificate authorities
Let's EncryptTag managers
Google Tag ManagerUI frameworks
BootstrapVideo players
YouTubeWeb servers
NginxAbout Alnylam Pharmaceuticals
SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work. We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861 Fraudulent Recruitment Activity Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
Specialties
Where is Alnylam Pharmaceuticals located?
Alnylam Pharmaceuticals lists 9 office locations.
Compare companies similar to Alnylam Pharmaceuticals
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Alnylam Pharmaceuticals alnylam.com | Biotechnology Research | 2,916 | 2002 | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Alnylam Pharmaceuticals
What does Alnylam Pharmaceuticals do?
SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work. We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861 Fraudulent Recruitment Activity Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
What technology does Alnylam Pharmaceuticals use?
Warmrank detected 36 technologies on alnylam.com, including Amazon SES, Amazon Web Services, Apple iCloud Mail, Atlassian, Bootstrap, DocuSign, Drupal, Fastly.
How many employees does Alnylam Pharmaceuticals have?
Alnylam Pharmaceuticals has around 2,916 employees on LinkedIn.
Where is Alnylam Pharmaceuticals headquartered?
Alnylam Pharmaceuticals is headquartered in Cambridge, Massachusetts.
Where does Alnylam Pharmaceuticals have offices?
Alnylam Pharmaceuticals lists 9 office locations, including Cambridge, Massachusetts, US; Amsterdam, North Holland, NL; Maidenhead, England SL6 8AA, GB; Milan, Lombardy, IT; Munich, Bavaria, DE.
When was Alnylam Pharmaceuticals founded?
Alnylam Pharmaceuticals was founded in 2002.
Build a lead list from companies like Alnylam Pharmaceuticals
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.